milk-thistle extract: Clinical Trials

5 trials of milk-thistle extract, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 terminated, 1 withdrawn. 5 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 2, Not yet recruiting 1, Terminated 1, Withdrawn 1
Phase 23Completed 1, Terminated 1, Withdrawn 1

Follow milk-thistle extract: new trials by email Literature Review of milk-thistle extract trials Research Report on milk-thistle extract

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Misocholic Tablets for Non-Viral Elevated Liver Enzymes
Misocholic Tab, Placebo, Silymarin (Silybum marianum) - Alcohol-Related Liver Disease, Drug-Induced Liver Injury
Phase 3Not yet recruitingHanoi Medical University602026-09-152026-09-22
Exercise, Milk Thistle, and Lactobacillus to Influence Plasma Bilirubin
Milk Thistle (MT), Lactobacillus Gasseri (LAC), Exercise (EX) - Obesity
Phase 3CompletedKyle Flack422021-02-242023-07-28
Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma
Silymarin, Placebo, chemotherapy - Upper GI Cancer, Cisplatin Adverse Reaction
Phase 2 / Phase 3CompletedTehran University of Medical Sciences302013-08-012015-05-13
Randomized Controlled Trial of Silymarin in Asthma
Oral Silymarin, Oral Silymarin, maintenance dose, Placebo - Atopic Asthma
Phase 2 / Phase 3WithdrawnVanderbilt University2010-09-012014-02-24
Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis
Silymarin, Lactose monohydrate - Acute Hepatitis A, Acute Hepatitis B
Phase 2 / Phase 3TerminatedUniversity of Maryland, Baltimore702008-10-012021-04-23

Conditions studied

Asthma (1)  ·  Chemical and Drug Induced Liver Injury (1)  ·  Gastrointestinal Neoplasms (1)  ·  Hepatitis (1)  ·  Motor Activity (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Obesity (1)  ·  Weight Loss (1)

Sponsors

Hanoi Medical University (1)  ·  Kyle Flack (1)  ·  Tehran University of Medical Sciences (1)  ·  University of Maryland, Baltimore (1)  ·  Vanderbilt University (1)

Countries

United States (2)  ·  Egypt (1)  ·  Iran (1)  ·  Vietnam (1)

Top investigators

George T Strickland, MD, PhD, (1)  ·  Mohamed Hashem, MD (1)  ·  Samer El-Kamary, MD, MPH (1)  ·  Simin Dashti-Khavidaki, Dr (1)  ·  Tina V. Hartert, MD, MPH (1)